NCT00606502 2021-03-05Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentSpectrum Pharmaceuticals, IncPhase 2 Completed201 enrolled 12 charts